Clinical Trial Update: Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase III placebo-controlled trial evaluating the Rotavirus vaccine V260 (RotaTeq) in Japanese healthy infants has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Rotavirus Infection

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus, Gastroenteritis | Phase 3 | Status: COMPLETED | Results posted: 2010-07-23